MRI biomarkers and their correlation with the Oncotype DX test

A Aranaz Murillo1, S Cruz Ciria1, A García Barrado1

  • 1Servicio de Radiología, Hospital Universitario Miguel Servet, Zaragoza, Spain.

Radiologia
|February 20, 2025
PubMed
Summary

Magnetic resonance imaging (MRI) and artificial intelligence (AI) show promise in predicting breast cancer recurrence scores. Standardizing these AI-MRI biomarkers could personalize early-stage breast cancer treatment decisions.